Explore N-Ethyl-N-isopropyllysergamide

Pfaff, RC; Huang, X; Marona-Lewicka, D; Oberlender, R; Nichols, DE. Lysergamides revisited. In Hallucinogens: An update. NIDA Research Monograph 146; Lin, GC; Glennon, RA, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, ; pp 52–73. 181 kB.

Huang, X; Marona-Lewicka, D; Pfaff, RC; Nichols, DE. Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives. Pharmacol. Biochem. Behav., 1 Mar 1994, 47 (3), 667–673. 650 kB. https://doi.org/10.1016/0091-3057(94)90172-4 #EIPLA

Nichols, DE. Chemistry and structure–activity relationships of psychedelics. In Behavioral Neurobiology of Psychedelic Drugs; Halberstadt, AL; Vollenweider, FX; Nichols, DE, Eds., Springer, 1 Jan 2017; pp 1-43. 2.6 MB. https://doi.org/10.1007/7854_2017_475

Nichols, DE. LSD and its lysergamide cousins. Heffter Rev., 1 Jan 2001, 2 (6), 80–87. 265 kB.

N-Ethyl-nor-LSD · ETH-LAD · ETHLAD

1-Methyl-LSD · MLD-41

N-Pentyllysergamide

2-APLA · 2-LSP · N-Pentan-2-yllysergamide

3-APLA · N-Pentan-3-yllysergamide · LSP

N-Ethyl-N-propyllysergamide · EPLA

N-tert-Butyllysergamide

6-Ethyl-MIPLA · Eth-LAMIDE

Metodesnitazene